Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Haworth

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in childrenGregory K Friedman, Elizabeth A Beierle, George Yancey Gillespie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2019
First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical TrialKeri A Streby, Mark A Currier, Melinda Triplet, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupCraig Erker, Benita Tamrazi, Tina Y Poussaint, et al.
Molecular Therapy Oncolytics|April 28, 2016
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivityJennifer L Leddon, Chun-Yu Chen, Mark A Currier, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in childrenGregory K Friedman, Elizabeth A Beierle, George Yancey Gillespie, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2019
First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical TrialKeri A Streby, Mark A Currier, Melinda Triplet, et al.
The Lancet. Oncology|June 6, 2020
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupCraig Erker, Benita Tamrazi, Tina Y Poussaint, et al.
Molecular Therapy Oncolytics|April 28, 2016
Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivityJennifer L Leddon, Chun-Yu Chen, Mark A Currier, et al.
Pageof 2